Drug and vaccine pricing and innovation: what is the story?

The author explores the links between drug, vaccine pricing and innovation in the U.S. He briefly discussed some implications of the pricing models for the analysis of changes in unit prices over time. The link between current or immediate past profit levels and the rate of research and development is included. The author also considered the investigation on whether there is a connection between the source and amount of funds for research and the price of new drug.